(Fighting New Coronary Pneumonia) The German government has ordered 130 million doses of vaccines and invested 50 million euros to fund the development of new coronavirus drugs
China News Agency, Berlin, January 6 (Reporter Peng Dawei) German Federal Minister of Health Spun announced on the 6th that, including the Modena vaccine approved by the European Union that day, Germany has ordered a total of Modena and BioNTech-Pfizer vaccines. More than 130 million doses will be delivered within the year.
The German Federal Ministry of Education and Research announced on the same day that it would invest 50 million euros to fund the research and development of drugs for the treatment of new coronary pneumonia by institutions and enterprises in the country.
The German disease control agency announced on the same day that the number of newly diagnosed new coronavirus infections was 21,237.
Real-time data from Germany's "Times Online" showed that as of 22:50 local time on the 6th, Germany had a total of 18,410,26 confirmed diagnoses, 1,450,431 cured, and 38,268 deaths.
As of 11 a.m. that day, Germany has vaccinated 367,331 people with the new crown vaccine.
On the 6th of this month, the European Union officially approved the use of Modena's new crown vaccine.
This is the second vaccine approved by the European Union for marketing following the BioNTech-Pfizer vaccine approved in December last year.
Span said at a press conference in Berlin that day that Germany’s current lag in the initial stage of vaccination is not because the government has ordered too few vaccines, but because the manufacturers’ production capacity is insufficient.
He promised that all people in Germany will get enough doses of vaccines, and everyone will get the opportunity to get vaccinated by this summer, "because we have ordered enough vaccines from multiple manufacturers."
Spang said that including the BioNTech-Pfizer vaccine and Modena vaccine, the German government has ordered more than 130 million doses of the new crown vaccine, and these vaccines will be delivered to Germany within the year.
On the same day, the German Federal Minister of Education and Research Kalicek announced that it would invest 50 million euros in funding research institutions and companies (located in Germany or with branches in Germany) to develop drugs for new coronary pneumonia.
Kalicek said that although the vaccine is already on the market, a safe and effective treatment is still essential to defeat the new crown epidemic.
She said that the funds will be used to fund clinical trials and product development of drugs for the treatment of new coronary pneumonia.
(Finish)